SE461334B - Cyklosporinderivat, foerfarande foer framstaellning daerav samt farmaceutisk komposition innehaallande naemnda derivat - Google Patents

Cyklosporinderivat, foerfarande foer framstaellning daerav samt farmaceutisk komposition innehaallande naemnda derivat

Info

Publication number
SE461334B
SE461334B SE8501392A SE8501392A SE461334B SE 461334 B SE461334 B SE 461334B SE 8501392 A SE8501392 A SE 8501392A SE 8501392 A SE8501392 A SE 8501392A SE 461334 B SE461334 B SE 461334B
Authority
SE
Sweden
Prior art keywords
cyclosporin
meleu
formula
val
nva
Prior art date
Application number
SE8501392A
Other languages
English (en)
Swedish (sv)
Other versions
SE8501392L (sv
SE8501392D0 (sv
Inventor
R Wenger
R P Traber
H Kobel
H Hofmann
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848407618A external-priority patent/GB8407618D0/en
Priority claimed from GB848411922A external-priority patent/GB8411922D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8501392D0 publication Critical patent/SE8501392D0/xx
Publication of SE8501392L publication Critical patent/SE8501392L/xx
Publication of SE461334B publication Critical patent/SE461334B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SE8501392A 1984-03-23 1985-03-21 Cyklosporinderivat, foerfarande foer framstaellning daerav samt farmaceutisk komposition innehaallande naemnda derivat SE461334B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848407618A GB8407618D0 (en) 1984-03-23 1984-03-23 Organic compounds
GB848411922A GB8411922D0 (en) 1984-05-10 1984-05-10 Organic compounds

Publications (3)

Publication Number Publication Date
SE8501392D0 SE8501392D0 (sv) 1985-03-21
SE8501392L SE8501392L (sv) 1985-09-24
SE461334B true SE461334B (sv) 1990-02-05

Family

ID=26287502

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8501392A SE461334B (sv) 1984-03-23 1985-03-21 Cyklosporinderivat, foerfarande foer framstaellning daerav samt farmaceutisk komposition innehaallande naemnda derivat

Country Status (24)

Country Link
US (1) US4639434A (enEXAMPLES)
JP (1) JPH08838B2 (enEXAMPLES)
AT (1) AT388737B (enEXAMPLES)
BE (1) BE901980A (enEXAMPLES)
CA (1) CA1247546A (enEXAMPLES)
CH (1) CH667274A5 (enEXAMPLES)
CS (1) CS249542B2 (enEXAMPLES)
DE (1) DE3509809A1 (enEXAMPLES)
DK (1) DK128285A (enEXAMPLES)
ES (1) ES8702926A1 (enEXAMPLES)
FI (1) FI851120A7 (enEXAMPLES)
FR (1) FR2561651B1 (enEXAMPLES)
GB (1) GB2155936B (enEXAMPLES)
GR (1) GR850716B (enEXAMPLES)
HU (1) HU200786B (enEXAMPLES)
IL (1) IL74681A (enEXAMPLES)
IT (1) IT1199962B (enEXAMPLES)
LU (1) LU85819A1 (enEXAMPLES)
NL (1) NL8500828A (enEXAMPLES)
NO (1) NO851160L (enEXAMPLES)
NZ (1) NZ211526A (enEXAMPLES)
PH (2) PH21868A (enEXAMPLES)
PT (1) PT80149B (enEXAMPLES)
SE (1) SE461334B (enEXAMPLES)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0198026B1 (en) 1984-10-04 1993-08-04 Sandoz Ag Monoclonal antibodies to cyclosporings
US4798823A (en) * 1987-06-03 1989-01-17 Merck & Co., Inc. New cyclosporin analogs with modified "C-9 amino acids"
EP0296122B1 (en) * 1987-06-17 1993-09-29 Sandoz Ag Cyclosporins and their use as pharmaceuticals
EP0373260B1 (en) * 1987-06-22 1994-03-09 Merck & Co. Inc. Cyclosporin derivatives with modified "8-amino acid"
US5227467A (en) * 1987-08-03 1993-07-13 Merck & Co., Inc. Immunosuppressive fluorinated cyclosporin analogs
WO1989001772A1 (en) * 1987-09-03 1989-03-09 University Of Georgia Research Foundation, Inc. Ocular cyclosporin composition
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin
US5089390A (en) * 1987-09-04 1992-02-18 Syntex (U.S.A.) Inc. 2-methyl-4-hexene- and 2-methyl-4-heptene-1,2-diol derivatives
US5236899A (en) * 1987-11-16 1993-08-17 Merck & Co., Inc. 6-position cyclosporin a analogs as modifiers of cytotoxic drug resistance
US4914188A (en) * 1987-11-16 1990-04-03 Merck & Co., Inc. Novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin
CH679119A5 (enEXAMPLES) * 1988-05-13 1991-12-31 Sandoz Ag
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
US5122511A (en) * 1990-02-27 1992-06-16 Merck & Co., Inc. Immunosuppressive cyclosporin analogs with modified amino acids at position-8
US5202310A (en) * 1990-06-06 1993-04-13 Levy Gary A Cyclosporine metabolites
FI111730B (fi) * 1990-11-02 2003-09-15 Novartis Ag Menetelmä ei-immunosuppressiivisen syklosporiinin valmistamiseksi
EP0674178B1 (en) 1990-11-20 2002-08-28 Dade Behring Marburg GmbH Cyclosporin immunoassay
US5747330A (en) * 1996-06-05 1998-05-05 Poli Industria Chimica Antibiotic producing microbe
RU2170741C2 (ru) * 1996-08-16 2001-07-20 Новартис Аг Способ получения циклоспорина
DE69840586D1 (de) 1997-10-08 2009-04-02 Isotechnika Inc Deuterierte Cyclosporin-analoga und ihre Verwendung als immunmodulierende Agenzien
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
US5990274A (en) * 1997-11-25 1999-11-23 Dade Behring Inc. Cyclosporine derivatives and uses thereof
US7449544B2 (en) * 1999-11-30 2008-11-11 Cyclacel Limited p21 peptides
EP1435910B9 (en) * 2001-10-19 2010-02-03 Isotechnika Inc. Novel cyclosporin analog microemulsion preconcentrates
SI1436321T1 (sl) 2001-10-19 2006-12-31 Isotechnika Inc Sinteza analogov ciklosporina
WO2004082629A2 (en) * 2003-03-17 2004-09-30 Albany Molecular Research, Inc. Novel cyclosporins
JP2008514701A (ja) * 2004-09-29 2008-05-08 エーエムアール テクノロジー インコーポレイテッド シクロスポリンアルキン類似体およびそれらの薬学的使用
US7511013B2 (en) * 2004-09-29 2009-03-31 Amr Technology, Inc. Cyclosporin analogues and their pharmaceutical uses
WO2006041631A2 (en) * 2004-10-06 2006-04-20 Amr Technology, Inc. Novel cyclosporin alkynes and their utility as pharmaceutical agents
US7696165B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
US7696166B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
WO2008069917A2 (en) 2006-11-20 2008-06-12 Scynexis, Inc. Novel cyclic peptides
AU2011342284C1 (en) 2010-12-15 2017-07-13 Contravir Pharmaceuticals, Inc. Cyclosporine analogue molecules modified at amino acid 1 and 3
PL3556774T3 (pl) 2011-03-11 2024-07-01 Beth Israel Deaconess Medical Center Inc. Przeciwciała anty-cd40 i ich zastosowania
CN104877013B (zh) * 2015-06-03 2018-04-20 兰州大学 环孢菌素t及其制备方法和应用
KR102779818B1 (ko) 2015-09-04 2025-03-11 프리마토프 테라퓨틱스 인크. 인간화 항-cd40 항체 및 그의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57140753A (en) * 1981-01-09 1982-08-31 Sandoz Ag Novel cyclosporine
EP0056782B1 (en) * 1981-01-09 1984-08-01 Sandoz Ag Novel cyclosporins

Also Published As

Publication number Publication date
DK128285D0 (da) 1985-03-21
IT8547852A0 (it) 1985-03-22
BE901980A (fr) 1985-09-23
ATA86385A (de) 1989-01-15
CA1247546A (en) 1988-12-28
JPH08838B2 (ja) 1996-01-10
GB8507270D0 (en) 1985-04-24
HUT38370A (en) 1986-05-28
PH23357A (en) 1989-07-14
FI851120L (fi) 1985-09-24
IL74681A0 (en) 1985-06-30
IT8547852A1 (it) 1986-09-22
NL8500828A (nl) 1985-10-16
FI851120A7 (fi) 1985-09-24
GR850716B (enEXAMPLES) 1985-07-19
FR2561651B1 (fr) 1990-03-09
SE8501392L (sv) 1985-09-24
FI851120A0 (fi) 1985-03-20
CS249542B2 (en) 1987-03-12
NZ211526A (en) 1988-08-30
PH21868A (en) 1988-03-25
CH667274A5 (de) 1988-09-30
DK128285A (da) 1985-09-24
PT80149A (en) 1985-04-01
US4639434A (en) 1987-01-27
ES8702926A1 (es) 1987-01-16
FR2561651A1 (fr) 1985-09-27
SE8501392D0 (sv) 1985-03-21
GB2155936B (en) 1987-09-16
IL74681A (en) 1989-09-10
LU85819A1 (fr) 1985-12-12
JPS60215700A (ja) 1985-10-29
NO851160L (no) 1985-09-24
ES541465A0 (es) 1987-01-16
IT1199962B (it) 1989-01-05
DE3509809A1 (de) 1986-01-09
PT80149B (en) 1987-03-23
HU200786B (en) 1990-08-28
GB2155936A (en) 1985-10-02
AT388737B (de) 1989-08-25

Similar Documents

Publication Publication Date Title
SE461334B (sv) Cyklosporinderivat, foerfarande foer framstaellning daerav samt farmaceutisk komposition innehaallande naemnda derivat
US4764503A (en) Novel cyclosporins
EP0056782B1 (en) Novel cyclosporins
JP2740775B2 (ja) 新規シクロスポリン類
JP2772372B2 (ja) シクロスポリン類およびそれらの医薬用途
US5502033A (en) Antimicrobial polypeptide compound a pharmaceutical composition comprising the same, and a method for treating infectious diseases
GB1567201A (en) Sandoz ltd
GB2212499A (en) Cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin
US5240910A (en) Antihypertensive compounds produced by fermentation
US7375230B2 (en) Fermentation and purification of migrastatin and analog
JPH07258132A (ja) 新規ヒドロキノン化合物
AU596071B2 (en) Novel cyclosporins
JPH0559046A (ja) 免疫調節剤
JPH05331171A (ja) プソイロチンｆ１／ｆ２、アスペルギルス・フミガタスから得られる新規な代謝産物、その調製方法およびその使用
JPH05331172A (ja) 生物活性プソイロチンａおよびｄ、アスペルギルス・フミガタスから得られる新規な代謝産物、その調製方法およびその使用
JPH0338280B2 (enEXAMPLES)
JP3124373B2 (ja) 免疫抑制物質
EP0818539A1 (en) Methylsulfomycin I, a process for its production and its use
JP2000510450A (ja) 群体ホヤ類のリッソクリヌム種からの環状ヘプタ―ペプチド誘導体
JP3160409B2 (ja) 抗ｈｉｖ活性ニベフラノン
JPH1129561A (ja) 新規化合物ａｍ６１０５及びその製法
JPH08301862A (ja) Ｐｅｎｉｃｉｌｌｉｕｍ種の抗生物質シリアノンおよびその化学誘導体並びにその製造法および使用
JPH07109299A (ja) 抗ｈｉｖ物質ペスタヒビン及びその誘導体
JPH0640995A (ja) 四環性化合物、その製造法および用途
JPH06256261A (ja) エンドセリン−１拮抗物質

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8501392-8

Effective date: 19911009

Format of ref document f/p: F